This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Astrazeneca Ab. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Certainly! Here is the article about inventor Jacqueline Anne Macritchie:
Title: Spotlight on Inventor Jacqueline Anne Macritchie
Introduction:
Jacqueline Anne Macritchie, a talented inventor hailing from Essex, GB, has made significant contributions to the field of pharmaceuticals with her innovative patent.
Latest Patents:
Jacqueline Anne Macritchie holds a remarkable patent for "Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors." This patent focuses on compounds that inhibit dipeptidyl peptidase 1 (DPP1) activity and their utility in treating respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD).
Career Highlights:
Currently affiliated with AstraZeneca AB, Jacqueline Anne Macritchie has showcased her expertise in drug development and pharmacology. Her dedication to enhancing therapies for respiratory conditions has garnered attention in the pharmaceutical industry.
Collaborations:
In her pursuit of innovation, Jacqueline Anne Macritchie has collaborated with esteemed professionals in the field, including coworkers like Hans Roland Lönn and Stephen Connolly. These collaborations have further enriched her research and development endeavors.
Conclusion:
In conclusion, Jacqueline Anne Macritchie's pioneering work in pharmaceuticals, particularly in the treatment of respiratory diseases, exemplifies her commitment to advancing healthcare solutions. With her inventive spirit and dedication to scientific exploration, she continues to make a significant impact in the industry.
Should you require further details or have any specific inquiries about inventor Jacqueline Anne Macritchie or related topics, feel free to explore our website for more information.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
